A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.
NCT ID: NCT06989255
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2024-11-06
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The data will be used to train an AI model within ThrombUS+ project to achieve automated detection of deep vein thrombosis on conventional ultrasound scans.
Primary objectives:
1. Collect and curate imaging data from ultrasound scans of patients suspected for DVT.
2. Collect accompanying metadata on patient demographics, referral note, existing known medical conditions at the time of scan, diagnosis based on the scan, operator anonymized ID, metadata on the ultrasound equipment used.
3. Anonymize the data set according to established regulations to be used for research purposes and in specific for training an artificial intelligence model to achieve automated DVT detection.
Secondary objectives:
1\. Describe the data set in the Argos/OpenAIRE tool and make it publicly available through the European Open Science Cloud (EOSC) portal via OpenAIRE, to be used by other researchers for image processing, analysis, and artificial intelligence (AI) model training.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Elasticity Imaging of Venous Thrombi
NCT00726947
Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging
NCT00677846
Ancillary Study of the ULTREC Project
NCT05300139
The Learning Curve of Emergency Physicians Performed Lower-extremity Ultrasonography in the Diagnosis of DVT
NCT04913688
Diagnostic Performance of General Practitioners in Compression UltraSound
NCT05550038
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Deep vein thrombosis (DVT) is the formation of a blood clot within the deep veins, most commonly those of the lower limbs, causing obstruction of blood flow. In 50% of people with DVT, the clot is at some point detached from the vein wall and travels to the lung to cause pulmonary embolism. About 25% of people experiencing pulmonary embolism (PE) will die from it, making it the 3rd leading cause of cardiovascular death worldwide after stroke and heart attack. Even in patients who do not get PE, recurrent thrombosis and "post-thrombotic syndrome" are major causes of mortality and reduced quality of life.
Recent European population studies report DVT incidence of 70-140 cases/100,000 person-year, which translates to roughly 522,000 to 1.04 million cases per year in Europe. Respectively, Center for Disease Control and Prevention (CDC) reports around 900,000 DVT incidents per year in USA, with an estimate of 60,000-100,000 related deaths per year. Venous thromboembolism (that collectively defines DVT and/or PE) during hospitalization is the leading cause of disability-adjusted life-years (DALYs) lost in low- and middle-income countries, and the second most common cause in high-income countries, causing loss of more DALYs than nosocomial pneumonia, catheter-related bloodstream infections, and adverse drug events. No identifiable provoking risk factor is reported in about 25%-40% of DVT and pulmonary embolism incidents. Surgery is reported to account for 15% of the cases and especially orthopaedic surgery with postoperative rates of around 1% reported despite pharmacological thromboprophylaxis; immobilization is reported to account for 15% and cancer for about 20% of cases.
Early diagnosis of DVT is crucial and has been proven to prevent life-threatening complications (pulmonary embolism), minimize the risk of long-term disability (post-thrombotic syndrome, recurrent DVT), improve treatment outcomes, and reduce healthcare costs. Despite the progress made in ultrasound imaging and plethysmography techniques, there is a need for new methods to enable continuous monitoring DVT diagnosis in hospitalized and other high-risk patients at the point of care.
ThrombUS+ EU Horizon project brings together an interdisciplinary team of industrial, technology, regulatory, social science and clinical trial experts to develop a novel wearable device for operator free, continuous monitoring in patients with high DVT risk. The devices and software to be developed during this project are expected to achieve automated early DVT detection, provide a continuous assessment of DVT risk and support DVT prevention via extended reality and serious gaming. ThrombUS+ wearable is intended for use by postoperative patients in the ward, during long surgical operations, cancer patients or otherwise bedridden patients at home or in care units, and women during pregnancy and postpartum. ThrombUS+ will use big data sets for artificial intelligence (AI) training collected in the project via 3 large scale clinical studies and will validate the outcome in the clinical setting via 1 early feasibility study and 1 multi-center clinical trial.
This study (ThrombUS\_Study\_A) aims to collect and create a labelled ultrasound image data set containing ultrasound images series of patients that undergo routine ultrasound scans on lower limbs, because of suspected deep vein thrombosis.
The data will be used to train AI models within ThrombUS+ project to achieve automated detection of deep vein thrombosis on conventional ultrasound scans.
The data set will include negative scans, positive for deep vein thrombosis scans, positive for other diagnosis scans and scans of insufficient quality to aid towards diagnosis, together with imaging metadata and a set of labels for each scan. In addition, the dataset will include pseudonymized patient demographics, referral note, existing known medical conditions at the time of scan, diagnosis based on the scan, operator anonymized ID, and metadata on the ultrasound equipment and scanning protocol parameters.
The data set will be completely anonymized to be used for research purposes, in compliance with the General Data Protection Regulation (GDPR) and the European Health Data Space (EHDS) and the upcoming Artificial Intelligence Act (AIA). Furthermore, the anonymized data set will be described in the Argos/OpenAIRE tool and will be made available through the European Open Science Cloud (EOSC) portal via OpenAIRE, to be used by other researchers for image processing, analysis, and AI model training. This is a non-interventional diagnostic image data collection study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with suspected DVT referred for a DVT ultrasound scan.
Patients with suspected DVT referred for a DVT ultrasound scan will be consecutively selected to account for demographics, medical condition and ultrasound operator diversity in the sample; data selected will be anonymized and included in the data set.
In and out-patients referred for an ultrasound scan for suspected DVT will be asked to participate (informed consent process).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant has the capacity to consent, and consent is obtained prior to any study-specific procedures.
* The conventional diagnostic DVT algorithm indicates that an ultrasound is needed, or the patient has been referred for a scan on suspicion of DVT.
Exclusion Criteria
* Patients considered by their treating physician or the ultrasound operator as non-suitable for a standard ultrasound scan.
* Patients who have not signed the informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ThrombUS+
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eleni Kaldoudi, Prof.
Role: STUDY_DIRECTOR
ATHENA Research Center, Greece
Andrius Macas, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Lithuanian University of Health Science [Lietuvos Sveikatos Mokslu Universitetas], Lithuania
Michail Potoupnis, Prof.
Role: PRINCIPAL_INVESTIGATOR
School of Medicine, Aristotle University of Thessaloniki and Papageorgiou General Hospital, Greece
Elvira Grandone, Prof.
Role: PRINCIPAL_INVESTIGATOR
Home Relief of Suffering Hospital [Fondazione Casa Sollievo Della Sofferenza], Italy
Maxime Gautier, Dr.
Role: PRINCIPAL_INVESTIGATOR
Simon Veil Hospital, France
Savvas Defteraios, Prof.
Role: PRINCIPAL_INVESTIGATOR
University General Hospital of Alexandroupoli, Greece
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupement Hospitalier Eaubonne Montmorency Simone Veil
Montmorency, , France
University General Hospital of Alexandroupoli
Alexandroupoli, , Greece
Papageorgiou General Hospital
Thessaloniki, , Greece
Home Relief of Suffering Hospital
San Giovanni Rotondo, , Italy
Lithuanian University of Health Science
Kaunas, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kaldoudi, E. et al. (2024). Towards Wearable Continuous Point-of-Care Monitoring for Deep Vein Thrombosis of the Lower Limb. In: Jarm, T., Šmerc, R., Mahnič-Kalamiza, S. (eds) 9th European Medical and Biological Engineering Conference. EMBEC 2024. IFMBE Proceedings, vol 113. Springer, Cham. https://doi.org/10.1007/978-3-031-61628-0_36
ThrombUS+: Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis, European Union, Horizon Europe Programme, Grant Agreement No, 101137227, 2024-2027, https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/projects-details/43108390/101137227
Maynard G, 2015, Preventing Hospital-Associated Venous Thromboembolism A Guide for Effective Quality Improvement, AHRQ Publication No. 16-0001-EF, https://www.ahrq.gov/sites/default/files/publications/files/vteguide.pdf
Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016 Dec 17;388(10063):3060-3073. doi: 10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30.
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.
ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014 Oct;12(10):1580-90. doi: 10.1111/jth.12698.
Nicholson M, Chan N, Bhagirath V, Ginsberg J. Prevention of Venous Thromboembolism in 2020 and Beyond. J Clin Med. 2020 Aug 1;9(8):2467. doi: 10.3390/jcm9082467.
Sharif-Kashani B, Behzadnia N, Shahabi P, Sadr M. Screening for deep vein thrombosis in asymptomatic high-risk patients: a comparison between digital photoplethysmography and venous ultrasonography. Angiology. 2009 Jun-Jul;60(3):301-7. doi: 10.1177/0003319708323494. Epub 2008 Oct 14.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Related Links
Access external resources that provide additional context or updates about the study.
Data management plan
ThrombUS+ EU funded project website
ThrombUS+ public repository at ZENODO
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101137227-A
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ThrombUS-Study-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.